Replies to post #179138 on Biotech Values

[jq1234]

Merck KGaA Terminates the License Agreement on Ceralifimod (ONO-4641) by Reaching Mutual Agreement with Ono Pharmaceutica

[One less competitor in 2nd generation of S1P space]

http://news.emdgroup.com/N/0/CA6B3B25E9032894C1257CFA001FE133/$File/OnoEMD.pdf